GoodRx Holdings Inc. (NASDAQ:GDRX) Stock Update and Financial Overview

Leerink Partners maintains an "Outperform" rating for GoodRx Holdings Inc. (NASDAQ:GDRX), indicating potential for above-market performance.The stock experienced a significant drop of 18.78% today, now priced at $1.99.GoodRx's recent Q4 2025 earnings call provided crucial insights into its financial health, with a focus on earnings, revenue, and profit margins.GoodRx Holdings Inc. (NASDAQ:GDRX) is a company that provides consumers with information and tools to compare prescription drug prices and find disco ...